An appeals court has revived a challenge to President Biden's Medicare drug price reduction program
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription ...
Challenge to US drug price negotiation program revived by appeals court
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...
Nearly 40 million people could die by 2050 due to antimicrobial resistance, study finds
The researchers estimated that, in 2050, the number of global deaths attributable to antimicrobial resistance could reach 1.9 ...
Opinion: A $22 billion life sciences engine vs. Washington red tape
Utah's life sciences sector is a significant economic powerhouse, but the misguided the Medication Affordability and Patent ...
Marketplace1d
Generic drugs in the U.S. face new economic pressures 40 years on
The generic drug industry in the U.S. has saved people billions of dollars, but shortages are now the norm and competition is ...
studyfinds1d
Scientists discover hundreds of new genes that may trigger cancer
BARCELONA, Spain — In a groundbreaking study that could reshape our understanding of cancer, scientists have uncovered a treasure trove of potential new targets for cancer treatment. This discovery ...
kffhealthnews1d
FDA Catches Indian Drugmaker Destroying Crucial Inspection Papers
The documents were needed to verify testing and manufacturing practices at Granules, a company in Telangana, India, that supplies generic medications to the U.S., officials say. More pharmaceutical ...
KVIA5d
Superbug crisis could get worse, killing nearly 40 million people by 2050, study estimates
The number of lives lost around the world due to infections that are resistant to the medications intended to treat them ...